Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pulmonary alveolar surface tension is the force exerted by water molecules at the air-liquid interface lining the alveoli in the lungs. It is a critical determinant of lung recoil and alveolar stability. Pulmonary surfactant, secreted by type II alveolar cells, reduces surface tension, preventing alveolar collapse and facilitating efficient gas exchange. Dysregulation of surface tension contributes to respiratory distress syndromes.
Exogenous surfactant reduces surface tension at the air-liquid interface in the alveoli.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pulmonary Alveolar Surface Tension.